Responding to concerns about paracetamol use in pregnancy

As US regulators flag new warnings on paracetamol use, the TGA and Australian experts have weighed in on what the evidence shows.

Naloxone nasal spray added to the PBS

With increasing overdose deaths from both prescription opioids and heroin, naloxone nasal spray – now listed on the Pharmaceutical Benefits Scheme – is a...

Five practice pointers for dispensing Paxlovid

Pfizer’s COVID-19 treatment Paxlovid (nirmatrelvir and ritonavir) will be listed on the Pharmaceutical Benefits Scheme (PBS) from 1 May. Here’s what pharmacists need to know.

Making a difference in mental health

One in six Australians receive a mental health-related prescription each year.1 Almost half the population is set to experience a mental health condition in...

Staying compliant with PBS regulations

To ensure PBS claiming practices are compliant, ethical and audit-ready, here’s what every pharmacist should know.

Flu cases surge to record highs as vaccination rates stall

While community pharmacists have smashed previous early-season influenza vaccination records, national coverage still lags dangerously.